Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 21;9(2):e16231.
doi: 10.2196/16231.

A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial

Jeb Jones  1 , Karen Dominguez  2 , Rob Stephenson  3 , Joanne D Stekler  4 , Amanda D Castel  5 , Leandro A Mena  6 , Samuel M Jenness  1 , Aaron J Siegler  2 , Patrick S Sullivan  1
Affiliations

A Theoretically Based Mobile App to Increase Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial

Jeb Jones et al. JMIR Res Protoc. .

Abstract

Background: HealthMindr is a mobile phone HIV prevention app for men who have sex with men (MSM). In a previous pilot study, HealthMindr was found to be acceptable among users and to demonstrate preliminary effectiveness for increasing pre-exposure prophylaxis (PrEP) uptake among MSM. PrEP is a highly effective HIV prevention intervention; however, uptake remains low.

Objective: The aim of this study will be to assess the efficacy of a mobile app for increasing PrEP uptake among MSM in the southern United States.

Methods: In this randomized controlled trial, we will assess the efficacy of HealthMindr for increasing PrEP uptake among MSM in the following three southern US cities: Atlanta, Georgia; Jackson, Mississippi; and Washington, DC. In total, 657 men will be recruited and randomized to intervention and control arms in a 2:1 ratio. Participants in the intervention arm will receive access to the full HealthMindr app, with information and resources about PrEP (eg, frequently asked questions, risk assessment tool, and PrEP provider locator), other HIV prevention information, ability to order free HIV/sexually transmitted infection test kits, and additional resources related to substance use and mental health. Participants in the control arm will use the HealthMindr app but will only have access to the study timeline and a message center to communicate with study staff. Participants will complete quarterly surveys to assess self-reported PrEP uptake over 12 months of follow-up. Self-reported PrEP uptake will be verified by dried blood spot testing and/or uploading a photograph of a PrEP prescription.

Results: Participant recruitment began in January 2020.

Conclusions: This trial will determine whether the HealthMindr app can increase PrEP uptake among MSM in the southern United States.

Trial registration: ClinicalTrials.gov NCT03763942; https://clinicaltrials.gov/ct2/show/NCT03763942.

International registered report identifier (irrid): PRR1-10.2196/16231.

Keywords: HIV; electronic health; men who have sex with men; mobile health; pre-exposure prophylaxis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: JDS reports involvement in HPTN 069/ACTG A5305 in which Gilead and ViiV contributed study medications and attending a Gilead Latinx Advisory Board Meeting in 2018. LAM reports funding from Gilead Sciences, Merck, ViiV Healthcare, and Roche.

Figures

Figure 1
Figure 1
Study schema depicting planned enrollment in each arm and the schedule of surveys and monthly self-assessments. PrEP: pre-exposure prophylaxis.
Figure 2
Figure 2
Screenshots of the splash screen, home page, and all about PrEP screen of the HealthMindr app. FAQ: frequently asked questions; PrEP: pre-exposure prophylaxis; STI: sexually transmitted infection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sullivan PS, Wolitski RJ. HIV infection among gay and bisexual men. In: Wolitski RJ, Stall R, Valdiserri RO, editors. Unequal Oppportunity: Health Disparities Affecting Gay and Bisexual Men in the United States. New York: Oxford University Press; 2007. pp. 220–47.
    1. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, Brookmeyer R. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012 Jul 28;380(9839):367–77. doi: 10.1016/S0140-6736(12)60821-6. http://europepmc.org/abstract/MED/22819660 - DOI - PMC - PubMed
    1. Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz AL, Altman D, Trapence G, Mayer K. The increase in global HIV epidemics in MSM. AIDS. 2013 Nov 13;27(17):2665–78. doi: 10.1097/01.aids.0000432449.30239.fe. - DOI - PubMed
    1. Centers for Disease Control and Prevention CDC HIV Surveillance Report. 2013. [2020-01-06]. Diagnoses of HIV Infection in the United States and Dependent Areas, 2011 https://www.cdc.gov/hiv/pdf/statistics_2011_HIV_Surveillance_Report_vol_....
    1. Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, Lin LS, An Q, Mermin J, Lansky A, Hall HI. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502. doi: 10.1371/journal.pone.0017502. http://dx.plos.org/10.1371/journal.pone.0017502 - DOI - DOI - PMC - PubMed

Associated data